Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
Figure 5-2: Global - Protein Therapeutics Market (Billion US$), 2014-2020
Figure 5-3: Global - Protein Therapeutics Market by Segment (%), 2014
Figure 7-1: Global - Erythropoietin Market (Billion US$), 2014-2020
Figure 8-1: Global - Number of Patients on Dialysis (Million), 2012-2014
Figure 8-2: Global - Breakup of Patients on Dialysis by Region (%), 2013
Figure 8-3: Global - Number of New Cancer Cases (Million), 2012 & 2030
Figure 8-4: Global - Breakup of New Cancer Cases by Region (%), 2012
Figure 8-5: Global - Share of US in EPO Market (2014)
Figure 9-1: Market Share of Major Players in the Erythropoietin Market (%), 2014
Figure 9-2: Roche Group - Break up of Revenue by Geography (%), 2014
Figure 9-3: Amgen Inc. - Break up of Revenue by Geography (%), 2014
Figure 9-4: Johnson & Johnson - Break up of Revenue by Geography (%), 2014

List of Tables:

Table 4-1: Some of the Erythropoietin Drugs which are Patented
Table 8-1: US - Sales of Key EPO Products (Billion US$), 2012-2014
Table 8-2: Global - Key Players and Drugs in Erythropoietin Alfa Market (Million US$), 2014
Table 8-3: Global - Key Players and Drugs in Erythropoietin Beta Market (Million US$), 2014
Table 8-4: Global - Key Players and Drugs in Darbepoetin Market (Million US$), 2014
Table 9-1: Roche Group - Key EPO Products
Table 9-2: Roche Group - Financial Performance (Million US$), 2012-2014
Table 9-3: Roche Group - Strengths and Weaknesses
Table 9-4: Amgen Inc. - Key EPO Products
Table 9-5: Amgen Inc. - Key Financials (Million US$), 2012-2014
Table 9-6: Amgen Inc. - Strengths and Weaknesses
Table 9-7: Johnson & Johnson - Key EPO Products
Table 9-8: Johnson & Johnson - Key Financials (Million US$), 2012-2014
Table 9-9: Johnson & Johnson - Strengths and Weaknesses